<DOC>
	<DOCNO>NCT01383304</DOCNO>
	<brief_summary>Previous study indicate patient cardiovascular disease variable response aspirin . Despite treatment aspirin large number patient suffer myocardial infarction . This give rise phenomenon `` aspirin low-responsiveness '' . Laboratory aspirin low-responsiveness defined failure aspirin inhibit platelet production thromboxane A2 inhibit thromboxane-dependent platelet aggregation . Whether low platelet response aspirin result increase risk future thrombotic event great clinical significance , still unknown . The investigator hypothesize patient reduce response aspirin , determine platelet aggregation use apparatus Verify Now Aspirin Multiplate , high risk thrombosis . The purpose study investigate whether high incidence cardiovascular event find patient coronary artery disease ( CAD ) reduce biochemical response aspirin compare CAD patient normal biochemical response aspirin . In addition CAD , patient least one follow risc factor : previous myocardial infarction , type 2 diabetes mellitus and/or renal insufficiency .</brief_summary>
	<brief_title>Aspirin Response High Risk Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Coronary artery disease verify coronary angiogram Treatment aspirin 75 mg/d least previous 7 day Previous myocardial infarction one year ago ( group previous myocardial infarction ) Type 2 diabetes mellitus treat oral antidiabetic and/or insulin ( group type 2 diabetes mellitus ) Renal insufficiency ; glomerular filtration rate &lt; 60 ml/min time blood sampling ( group renal insufficiency ) Treatment NSAIDs , clopidogrel , ticlopidine , dipyridamole , warfarin drug know affect platelet function Ischemic vascular event within previous 12 month Revascularization ( angioplasty coronary bypass graft surgery ) within previous 12 month Platelet count &lt; 120 x 10^9/L &gt; 450 x 10^9/L For patient without diabetes : fast glucose &gt; 7 mmol/L Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Platelet aggregation</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Drug resistance</keyword>
	<keyword>Thromboxane B2</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
</DOC>